Free shipping on all orders over $ 500

Nimotuzumab

Cat. No. M1512

All AbMole products are for research use only, cannot be used for human consumption.

Nimotuzumab Structure
Synonym:

CAS# 780758-10-3

Size Price Availability Quantity
100ug USD 230  USD230 In stock
1mg USD 560  USD560 In stock
5mg USD 1700  USD1700 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Nimotuzumab (Nimotuzumab) is the first humanized monoclonal antibody targeting epidermal growth factor receptor (EGFR). Nimotuzumab has cytolytic effects on target tumors through its ability to induce antibody-dependent cell-mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC). EGFR is overexpressed in a variety of solid tumors, such as head and neck cancer, lung cancer and colorectal cancer. EGFR overexpression is highly associated with high aggressiveness, high metastasis, and poor prognosis. Nimotuzumab can competitively bind EGFR and block downstream signal transduction pathway mediated by EGFR, thereby inhibiting tumor cell proliferation, inducing differentiation, promoting apoptosis and inhibiting tumor angiogenesis. Nimotuzumab failed to recognize mouse EGFR.

Another CAS# 780758-10-3

Chemical Information
Molecular Weight 147656.97
Formula C6566H10082N1746O2056S40
CAS Number 828933-51-3
Storage -80°C for long term
References

[1] Ramakrishnan MS, et al. MAbs. Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin.

Related EGFR/HER2 Products
AEE788

AEE788 (NVP-AEE788) is a novel multitargeted HER 1/2 and VEGFR 1/2 receptor family tyrosine kinases inhibitor with IC50 of 2, 6, 77, 59 nM for EGFR, ErbB2, KDR, and Flt-1.

Sapitinib (AZD8931)

AZD8931 (Sapitinib) is an equipotent, reversible inhibitor of Signaling by EGFR, ERBB2 (HER2), and ERBB3 with IC50 of 4, 3, 4 nM respectively.

Afatinib

Afatinib (BIBW 2992) is a novel irreversible dual EGFR and HER2 tyrosine kinase inhibitor.

CP-724714

CP-724714 is a potent and selective orally active HER-2 tyrosine kinase inhibitor, IC50 = 3 nM.

Erlotinib Hydrochloride

Erlotinib is an inhibitor of human EGFR tyrosine kinase (IC50 = 2 nM) and decreases EGFR autophosphorylation in tumor cells (IC50 = 20 nM).

  Catalog
Abmole Inhibitor Catalog




Keywords: Nimotuzumab, CAS# 780758-10-3 supplier, EGFR/HER2, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.